• 1
    World Health Organization. Leptospirosis worldwide, 1999. Wkly Epidemiol Rec 1999; 74: 237244.
  • 2
    World Health Organization (WHO) and International Leptospirosis Society (ILS). Leptonet 2005. Available at:
  • 3
    Agampodi S, Peacock SJ, Thevanesam V. The potential emergence of leptospirosis in Sri Lanka. Lancet Infect Dis 2009; 9: 524526.
  • 4
    Koizumi N, Gamage CD, Muto M et al. Serological and genetic analysis of leptospirosis in patients with acute febrile illness in Kandy, Sri Lanka. Jpn J Infect Dis 2009; 62: 474475.
  • 5
    McCurry J. Philippines struggles to recover from typhoons. Lancet 2009; 9700: 1489.
  • 6
    Levett PN. Leptospirosis. Clin Microbiol Rev 2001; 14: 196326.
  • 7
    World Health Organization. Human Leptospirosis: Guidance for Diagnosis, Surveillance and Control. Geneva, Switzerland: WHO, 2003.
  • 8
    Bharti AR, Nally JE, Ricardi JN et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 2003; 3: 757771.
  • 9
    Ellis WA. Leptospirosis as a cause of reproductive failure. Vet Clin N Am – Food Anim Pract 1994; 10: 463478.
  • 10
    Ellis WA, O’Brien JJ, Cassells JA et al. Excretion of Leptospira interrogans serovar hardjo following calving or abortion. Res Vet Sci 1985; 39: 296298.
  • 11
    Ellis WA, McParland PJ, Bryson DG et al. Isolation of leptospires from the genital tract and kidneys of aborted sows. Vet Rec 1986; 118: 294295.
  • 12
    Ellis WA, McParland PJ, Bryson DG et al. Boars as carriers of leptospires of the Australis serogroup on farms with an abortion problem. Vet Rec 1986; 118: 563.
  • 13
    Ganoza CA, Matthias MA, Saito M et al. Asymptomatic renal colonization of humans in the Peruvian Amazon by Leptospira. PLoS NTD 2010; 4: e612.
  • 14
    Reilly JR, Hanson LE, Ferris DH. Experimentally induced predator chain transmission of Leptospira grippotyphosa from rodents to wild marsupialia and carnivora. Am J Vet Res 1970; 31: 14431448.
  • 15
    World Health Organization. Fatal leptospirosis, Azores Islands. Wkly Epidemiol Rec 2001; 76: 109111.
  • 16
    Hartskeerl RA, Smits HL, Korver H et al. International Course on Laboratory Methods for the Diagnosis of Leptospirosis, Course Manual. Amsterdam, The Netherlands: Royal Tropical Institute, 2006.
  • 17
    Vieira ML, Gama-Simões MJ, Collares-Pereira M. Human Leptospirosis in Portugal: a retrospective study of eighteen years. Int J Infect Dis 2006; 10: 378386.
  • 18
    Hartskeerl RA. Leptospirose: een onderschatte infectieziekte. Ned Tijdschr Med Microbiol 2003; 11: 9498.
  • 19
    McBride AJA, Athanazio DA, Reis MG et al. Leptospirosis. Curr Opin Infect Dis 2005; 18: 376386.
  • 20
    Sanders EJ, Rigau-Perez JG, Smits HL et al. Increase of leptospirosis in dengue-negative patients after a hurricane in Puerto Rica in 1996. Am J Trop Med Hyg 1999; 61: 935941.
  • 21
    Ko AI, Reis MG, Dourado CMR et al. Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet 1999; 354: 820825.
  • 22
    Zaki RS, Shieh W-J, and the Epidemic Working Group.. Leptospirosis associated with outbreak of acute febrile illness and pulmonary haemorrhage, Nicaragua, 1995. Lancet 1996; 347: 535.
  • 23
    Chappel RJ, Goris M, Palmer MF et al. Impact of proficiency testing on results of the microscopic agglutination test for diagnosis of leptospirosis. J Clin Microbiol 2004; 42: 54845488.
  • 24
    Katz AR, Ansdell VE, Effler PV et al. Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii, 1874-1998. Clin Infect Dis 2001; 33: 18341841.
  • 25
    Watt G, Padre LP, Tuazon ML et al. Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet 1988; 1: 433435.
  • 26
    Hartskeerl RA, Hartman DG, Moens AR. Advies Leptospirose. Den Haag, The Netherlands: Interdepartementale Werkgroep Zoönosen, 2001.
  • 27
    Painter JA, Mølbak K, Sonne-Hansen J et al. Salmonella-based rodenticides and public health. Em Infect Dis 2004; 10: 985987.
  • 28
    Ellis WA, Montgomery J, Cassells JA. Dihydrostreptomycin treatment of bovine carriers of Leptospira interrogans serovar hardjo. Res Vet Sci 1985; 39: 292295.
  • 29
    O.I.E. (Office International des Epizooties). Leptospirosis. In: EllisWA, ed, O.I.E. Manual of Recommended Diagnostic Techniques and Requirements for Biological Products for List A and B Diseases, Vol. II. Paris: O.I.E.. 1990;11.
  • 30
    Bolin CA, Thiermann AB, Handsaker A et al. Effect of vaccination with a pentovalent leptospiral vaccine on Leptospira interrogans serovar hardjo type hardjo-bovis infection of pregnant cattle. Am J Vet Res 1989; 50: 161165.
  • 31
    Bolin CA, Alt DP. Use of a monovalent leptospiral vaccine to prevent venal colonization and urinary shedding in cattle exposed to Leptospira borgpetersenii serovar hardjo. Am J Vet Res 2001; 62: 9951000.
  • 32
    Ellis WA, Yan KT, McDowell SWJ et al. Immunity to bovine leptospirosis. Proceedings of 21st World Buiatrics Congress 2000: 1060110611.
  • 33
    Faisal SM, Yan W, McDonough SP et al. Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity. Vaccine 2009; 3: 378387.
  • 34
    Brown RA, Blumerman S, Gay C et al. Comparison of three different leptospiral vaccines for induction of a type 1 immune response to Leptospira borgpetersenii serovar Hardjo. Vaccine 2003; 21: 44484458.
  • 35
    Chen TZ. Development and situation of, and techniques for production of leptospirosis vaccine in China. Jpn J Bacteriol 1985; 40: 755762.
  • 36
    Martinez-Sanches R, Obregon-Fuentes AM, Perez-Sierra A et al. The reactogenicity and immunogenicity of the first Cuban vaccine against human leptospirosis. Rev Cubana Med Trop 1998; 50: 159166.
  • 37
    Martinez-Sanches R, Perez-Sierra A, Baro-Suarez M et al. Evaluation of the effectiveness of a new vaccine against human leptospirosis in groups at risk. Rev Panam Salud Publica 2000; 8: 385392.
  • 38
    Laurichesse H, Gourdon F, Smits HL et al. Safety and immunogenicity of subcutaneous or intramuscular administration of a monovalent inactivated vaccine against Leptospira interrogans serogroup Icterohaemorrhagiae in healthy volunteers. Clin Microbiol Infect 2007; 13: 395403.
  • 39
    Ikoev VN, Gorbunov MA, Vachaev BF et al. The evaluation of the reactogenicity and immunogenic activity of a new concentrated inactivated leptospirosis vaccine. Zh Mikrobiol Epidemiol Immunobiol 1999; 4: 3943.
  • 40
    Pappas G, Papadimitriou P, Siozopoulou Y et al. The globalization of leptospirosis: worldwide incidence trends. Int J Infect Dis 2008; 12: 315357.
  • 41
    World Health Organization. The Leptospirosis Burden Epidemiology Reference Group (LERG). Available at:
  • 42
    World Health Organization. Leptospirosis, India: report of the investigation of a post-cyclone outbreak in Orissa, November 1999. Wkly Epidemiol Rec 2000; 75: 217223.
  • 43
    Hartskeerl RA. Leptospirosis: current status and future trends. Indian J Med Microbiol 2006; 24: 309.
  • 44
    Hotez PJ, Molyneux DH, Fenwick A et al. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria: a comprehensive pro-poor health policy and strategy for the developing world. PLoS Med 2006; 3: e102.
  • 45
    Lioyd-Smith JO, George D, Pepin KM et al. Epidemic dynamics at the human-animal interface. Science 2009; 326: 12621367.
  • 46
    Triampo W, Baowan D, Tang IM et al. A simple deterministic model for the spread of leptospirosis in Thailand. Int J Biol Med Sci 2007; 2: 2226.
  • 47
    Holt J, Davis S, Leirs H. A model of leptospirosis infection in an African rodent to determine risk to humans: seasonal fluctuations and the impact of rodent control. Acta Trop 2006; 99: 218225.
  • 48
    Codeço CT, Lele S, Pascual M et al. A stochastic model for ecological systems with strong nonlinear response to environmental drivers: application to two water-borne diseases. J R Soc Interface 2008; 5: 247252.
  • 49
    Luber G, Prudent N. Climate Change and Human Health. Trans Am Clin Climatol Assoc 2009; 120: 113117.
  • 50
    Abela-Ridder B, Sikkema R, Hartskeerl RA. Estimating the burden of human leptospirosis. Int J Antimicrob Agents 2010; 36 (Suppl. 1): 57.
  • 51
    World Health Organization. Report of the first meeting of the Leptospirosis Burden Epidemiology Reference Group. WHO, Department of Food Safety and Zoonoses: Geneva, Switzerland, 2010.
  • 52
    Office International des Epizooties (OIE), World Health Organization (WHO). Global Early Warning and Response System (GLEWS): One world, one health. Available at:
  • 53
    Yan KT, Ellis WA, Mackie DP et al. Development of an ELISA to detect antibodies to a protective lipopolysaccharide fraction of Leptospira borgpetersenii serovar hardjo in cattle. Vet Microbiol 1999; 69: 173187.
  • 54
    Dias TD, Mota-Vieira L, Collares-Pereira M. Factores preditivos potenciais da ocorrência de Leptospirose humana em São Miguel (Açores): estudo laboratorial retrospectivo (2004 – 2008). License degree of ESTSP, Oporto, under the Azores Leptospirosis Project (2004-2008), 2009 USA Scientific Cooperative Agreement No. 58-4001-3-F185. Available at:
  • 55
    Slack A, Symonds M, Dohnt M et al. Evaluation of a modified Taqman assay detecting pathogenic Leptospira spp. against culture and Leptospira-specific IgM enzyme-linked immunosorbent assay in a clinical environment. Diagn Microbiol Infect Dis 2007; 57: 361366.
  • 56
    Ahmed A, Engelberts MFM, Boer RK et al. Development and validation of a real-time PCR detection of pathogenic Leptospira species in clinical materials. PLoS ONE 2009; 9: e7093.
  • 57
    McBride AJA, Santos BL, Queirox A et al. Evaluation of four whole-cell Leptospira-based serological tests for the diagnosis of urban leptospirosis. Clin Vac Immunol 2007; 14: 12451248.